Self-adjuvanting multi-protein complexes for modular vaccine production
AssigneeDesign-Zyme LLC
InventorsPeter Albert Petillo, Dwight O'Dell Deay, III, Mary Beth Carter
Life of this patent
Estimating the term…
Loading patent…
AssigneeDesign-Zyme LLC
InventorsPeter Albert Petillo, Dwight O'Dell Deay, III, Mary Beth Carter
Estimating the term…
The present invention is broadly concerned with a vaccine composition comprising a central carrier, at least one linear carbohydrate molecule, and at least one immunogen molecule, wherein each of the at least one linear carbohydrate molecule and at least one immunogen molecule are covalently bound to the carrier via respective covalent linkages. Vaccine compositions comprising multivalent carriers and related methods may find various therapeutic and prophylactic applications for inducing an immune response against, treating, or preventing a bacterial, viral, fungal, or protozoan infection, including, but are not limited to, coronaviruses, Lyme Disease, Chlamydia, and the related diseases thereof.
A vaccine composition comprising a multivalent carrier covalently attached to one or more linear carbohydrate molecules and a plurality of immunogen molecules, said one or more linear carbohydrate molecules each attached to said multivalent carrier via a reducing end of said linear carbohydrate molecules.
A kit, comprising a multivalent carrier covalently attached to one or more linear carbohydrate molecules and a plurality of immunogen molecules.
A kit, comprising a multivalent carrier covalently attached to one or more linear carbohydrate molecules.
Dependencies are inferred from the claim text.